Barclays’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
56,905
+21,874
| +62% | +$119K | ﹤0.01% | 3299 |
|
|
2025
Q1 | $123K | Sell |
35,031
-7,457
| -18% | -$26.2K | ﹤0.01% | 3601 |
|
|
2024
Q4 | $438K | Buy |
42,488
+13,476
| +46% | +$139K | ﹤0.01% | 3132 |
|
|
2024
Q3 | $393K | Buy |
29,012
+18,710
| +182% | +$253K | ﹤0.01% | 3124 |
|
|
2024
Q2 | $134K | Sell |
10,302
-5,730
| -36% | -$74.5K | ﹤0.01% | 3244 |
|
|
2024
Q1 | $152K | Sell |
16,032
-10,704
| -40% | -$101K | ﹤0.01% | 3466 |
|
|
2023
Q4 | $294K | Buy |
26,736
+23,226
| +662% | +$255K | ﹤0.01% | 3324 |
|
|
2023
Q3 | $23K | Sell |
3,510
-450
| -11% | -$2.95K | ﹤0.01% | 3876 |
|
|
2023
Q2 | $19K | Sell |
3,960
-2,514
| -39% | -$12.1K | ﹤0.01% | 3983 |
|
|
2023
Q1 | $27K | Buy |
6,474
+3,080
| +91% | +$12.8K | ﹤0.01% | 3934 |
|
|
2022
Q4 | $14K | Sell |
3,394
-25,356
| -88% | -$105K | ﹤0.01% | 4089 |
|
|
2022
Q3 | $546K | Buy |
+28,750
| New | +$546K | ﹤0.01% | 2537 |
|